SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Statement re: Valuation Reporting Frequency

12 Feb 2010 09:31

RNS Number : 0700H
J.P. Morgan Private Equity Ltd
12 February 2010
Β 

ο»Ώ

J.P. Morgan Private Equity Increases Frequency of Private Equity Valuation Reporting

Β * * *

GUERNSEY, 12 FEBRUARY 2010

J.P. Morgan Private Equity Limited ("JPEL" or the "Company"), the London Stock Exchange listed private equity secondary fund, is pleased to announce that the Company will be increasing the frequency of the reporting and valuation of its private equity portfolio.

Since the Company's IPO at June 2005, JPEL has updated the values of its private equity portfolio on a quarterly basis. Beginning with the month that ended 31 January 2010, the Company began valuing its private equity portfolio on a monthly basis.

Since inception, JPEL has always placed emphasis on investor communications and reporting. Increasing the frequency of valuations for the private equity portfolio is a logical and welcomed continuation of this effort. The Manager believes that reporting private equity valuations twelve times per year will enable the Manager to efficiently communicate its activity in the secondary market as well as the overall performance of the portfolio.

JPEL's primary strategy is to acquire secondary market portfolios of direct fund investments, significantly invested partnership interests and partially drawn commitments, in order to accelerate NAV development. JPEL employs an opportunistic, deep value private equity investment strategy and focuses on value-oriented investments with potential for early return of capital. From inception through 31 December 2009, JPEL's NAV per US$ Equity Share has grown 25.5% versus declines of 6.4% and 47.5% in the S&P 500 and LPX indices, respectively.

Please refer to page 2 of this press release for additional information on JPEL's Valuation and Reporting Policy.

* * *

About J.P. Morgan Private Equity Limited

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. The Company's capital structure consists of three classes of shares: Equity Shares and two classes of Zero Dividend Preference Shares due 2013 and 2015, respectively. JPEL issued warrants free of subscription cost to shareholders on record as of 17 August 2009. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

J.P. Morgan Private Equity LimitedTroy Duncan / Gregory Getschow Telephone: +44 (0) 20 7742 3032 / +1 212 648 1150

Rosemary DeRise Telephone: + 1 212 648 2980

Peregrine CommunicationsAnthony Payne Telephone: +44 (0) 20 3178 6869

* * *

Β 

VALUATION POLICY AND METHODOLOGY

Valuation reporting policy

Β 

The Net Asset Value of the Company is calculated by HSBC Management (Guernsey) Limited and published monthly with the relevant Valuation Point being 5.00 p.m. (Guernsey time) on the last Business Day of each month. Each monthly Net Asset Value is published through a Regulatory News Service (RNS) announcement normally within 20 Business Days of such month end. Valuations produced by the Manager as at the relevant month end are conclusive and binding on all Shareholders. In addition to the planned new reporting cycle described above, theΒ Company and theΒ Manager may, inΒ their sole discretion, arrange for additional valuations to be published orΒ extend the 20 Business Day periodΒ to cater for exceptional circumstances or significant new developments.

Β 

Β 

Private equity valuation methodology

The Board values the investments in the Private Equity Portfolio on the Manager's advice by following the recommendations of either the International Private Equity and Venture Capital Valuation Guidelines (IPEVCG) or standard industry practice. For unquoted fund investments, the value is the most recent valuation placed on a fund by the respective private equity manager, although the Manager may recommend to the Board that an adjustment to such valuation be made if necessary to reflect cash flows between the Company and the fund(s) concerned which occur between the private equity manager's valuation date and the Company's monthly valuation dates. In the event that the Company directly holds publicly traded portfolio companies, the Manager may recommend that an adjustment to such valuation be made if necessary. The Manager will endeavour to include the most recent valuations received by the respective private equity manager at the time in which the monthly Net Asset Value is published.

Β 

The valuation policies used by many of the private equity managers in undertaking such valuations is generally in line with the recommendations of either the International Private Equity and Venture Capital Valuation Guidelines (IPEVCG) or standard industry practice.

Β 

All valuations of fund interests include a provision for carried interest, where appropriate, payable to the relevant private equity sponsor.

Β 

While the Board's normal policy is to adopt the private equity manager's valuations and to reflect in the valuation of the Company Portfolio any adjustment to the valuation of their respective funds made by private equity sponsors, on occasions it may depart from this policy in the following circumstances:

Β 

Β·; the Manager may recommend the Board not to adopt an upwards adjustment if in its opinion the adjustment made or proposed by the relevant private equity manager is not prudent;

Β·; the Manager may recommend that the Board make a downward adjustment to the valuation of a fund interest in the Company Portfolio which has not been made or proposed by the private equity manager if they receive relevant information which has not been notified to them by the private equity manager or if they form a different and more cautious view than that held by the private equity manager; and

Β·; the Manager may recommend that the Board make an upward adjustment to the valuation of a fund interest in the Company Portfolio which has not been made or proposed by the private equity manager if they receive relevant information that has occurred subsequent to the issuance of the general partner valuation, such as in cases of announcements of the pending public offering or sale of a portfolio company.

Β 

Secondary Portfolios

The Company may acquire secondary interests at either a premium or a discount to the respective private equity sponsor's valuation by following the International Private Equity and Venture Capital Valuation Guidelines. The Company will maintain values for any secondary interests at the price at which they were purchased until the receipt of the first valuation report from the respective private equity sponsor after the date of acquisition, at which point the acquired interests will be valued according to the Company's standard ongoing valuation methodology.

Β 

The calculation of the Net Asset Value will only be suspended in circumstances where the underlying data necessary to value the investments of the Company cannot readily, or without undue expenditure, be obtained. Details of any suspension in making such calculations will be announced through an RNS.

Β 

* * *

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STRTTMLTMBJBMMM
Date   Source Headline
18th Nov 20207:00 amRNSStatement re Company Update
13th Nov 20202:49 pmRNSNet Asset Value - August 2020
9th Nov 20204:43 pmRNSNet Asset Value - July 2020
4th Nov 20209:35 amRNS2020 AGM CIRCULAR
8th Oct 20207:00 amRNSAnnual Financial Report - 30 June 2020
16th Sep 202011:55 amRNSNet Asset Value - June 2020
31st Jul 20203:05 pmRNSNet Asset Value - May 2020
24th Jun 20207:00 amRNSNet Asset Value - April 2020
10th Jun 202011:04 amRNSNet Asset Value - March 2020
24th Apr 20207:00 amRNSNet Asset Value - February 2020
14th Apr 20204:47 pmRNSNet Asset Value - January 2020
14th Apr 20203:35 pmRNSNet Asset Value - January 2020
14th Apr 20203:16 pmRNSHolding(s) in Company
1st Apr 20205:35 pmRNSReplacement Completion of 7th Mandatory Redemption
1st Apr 20203:33 pmRNSCompletion of Seventh Mandatory Redemption
25th Mar 20207:00 amRNSSeventh Mandatory Redemption
17th Mar 20203:46 pmRNSHalf-year Report - 31 December 2019
13th Mar 20207:00 amRNSPartial Sale of 2nd Largest Investment
6th Mar 20204:51 pmRNSNet Asset Value(s) - December 2019
10th Jan 20203:21 pmRNSNet Asset Value - November 2019
5th Dec 20194:56 pmRNSNet Asset Value(s) - October 2019
26th Nov 20197:00 amRNSAGM Results 2019
15th Nov 20196:23 pmRNSNet Asset Value(s) - September - Replacement
15th Nov 20195:52 pmRNSNet Asset Value(s) - September
15th Nov 20195:51 pmRNSNet Asset Value(s) - August 2019
15th Nov 20195:51 pmRNSNet Asset Value(s) - July 2019
5th Nov 20195:42 pmRNS2019 AGM CIRCULAR
22nd Oct 20197:00 amRNSCompletion of Sixth Mandatory Redemption
9th Oct 20193:28 pmRNSSixth Mandatory Redemption
27th Sep 201910:48 amRNSAnnual Financial Report - 30 June 2019
10th Sep 20191:19 pmRNSNet Asset Value(s) - June 2019
12th Jul 20197:00 amRNSNet Asset Value(s) - May 2019
13th Jun 20197:00 amRNSNet Asset Value(s) - April 2019
17th May 20197:00 amRNSNet Asset Value(s) - March 2019
5th Apr 20197:00 amRNSNet Asset Value(s) - February 2019
19th Mar 20193:57 pmRNSHalf-year Report - 31 December 2018
13th Mar 20197:00 amRNSNet Asset Value(s)
7th Feb 201910:55 amRNSNet Asset Value(s) - December 2018
22nd Jan 201910:10 amRNSNet Asset Value(s) - November 2018
8th Jan 20197:00 amRNSCompletion Of Fifth Mandatory Redemption
10th Dec 20183:58 pmRNSMandatory Redemption - US$Equity Shares - Dec 2018
6th Dec 20183:28 pmRNSHolding(s) in Company
30th Nov 20183:21 pmRNSNet Asset Value(s) - October 2018
27th Nov 201811:08 amRNSAGM Results 2018
7th Nov 20187:00 amRNS2018 AGM CIRCULAR
30th Oct 20187:00 amRNSNet Asset Value(s) - August 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - July 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - September 2018
12th Oct 20184:32 pmRNSHolding(s) in Company
4th Oct 20182:42 pmRNSNotification of Dealings in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.